microdosing tirzepatide vs semaglutide for Semaglutide vs. Tirzepatide for Weight

P.FrettX.et al (2021)

Incretin-based drugs fall into two main categories: DPP-4 inhibitors (like sitagliptin and linagliptin), which block the enzyme that degrades incretin hormones to boost insulin and reduce glucagon levels, and GLP-1 analogues (such as liraglutide and dulaglutide), which mimic natural GLP-1 to enhance insulin release, slow digestion, and promote satiety

Semaglutide + BPC-157 peptide therapy offers benefits such as metabolic support, weight management, anti-inflammatory effects, tissue repair, and gut health support for women seeking to optimize their overall well-being

With consistent use, it enhances brightness, smooths rough patches, and promotes an even-toned appearance